Keyphrases
21-gene
9%
21-gene Recurrence Score
100%
5-year Survival
27%
Breast Cancer
100%
Breast Reconstruction
100%
Chemotherapy
9%
Clinical Factors
9%
Cox Proportional Hazard Analysis
9%
ER +
18%
Female Patients
9%
High Risk
18%
High-risk Population
36%
Hormone Receptor-positive
9%
Human Epidermal Growth Factor Receptor 2-negative
18%
Intermediate Risk
54%
Kaplan-Meier Analysis
9%
Low Risk
54%
Matched Cohort
9%
Multivariable
27%
National Cancer Database
9%
Negative Breast Cancer
9%
Overall Survival
36%
Overall Survival Benefit
9%
Patient's Will
9%
Prognostic Benefit
100%
Prognostic Factors
9%
Propensity Score Matching
18%
Prospective Evaluation
9%
Radiation Therapy
100%
Recurrence Risk
18%
Recurrence Score
63%
Selection Criteria
9%
T1N0
100%
Treatment Factors
9%
Medicine and Dentistry
Breast Cancer
100%
Epidermal Growth Factor Receptor 2
18%
Gamma Urogastrone
18%
Hormone Receptor
9%
Kaplan Meier Method
9%
Malignant Neoplasm
9%
Overall Survival
72%
Prognostic Factor
18%
Propensity Score Matching
18%
Proportional Hazards Model
9%
Quadrantectomy
100%
Radiation Therapy
100%
Recurrence Risk
18%
Recurrent Disease
100%
Neuroscience
Epidermal Growth Factor Receptor 2
18%
Gamma Urogastrone
18%
Hormone Receptor
9%
Radiation Therapy
100%